In PR-transfected or estrogen receptor-negative breast cancer cells, DNA synthesis and cell proliferation are markedly inhibited by P4 treatment, indicating a receptor-dependent role for P4 in tumor growth inhibition [13]. This evidence concerns the gene ESR1 and neoplasm.